EVALUATION OF THE IMPACT OF IMAGE PET amyloid-BETA IN THE DIAGNOSIS AND CONTROL CLINIC OF patients with cognitive impairment EVALUATED BY SUSPECTED Alzheimer's disease (AD).

Project Number
EUJPND-SpainISC-ARBIZU LOSTAO-1309
Agency/Funding Organization
INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD
Funding Year
2016
View Full Project Details for EVALUATION OF THE IMPACT OF IMAGE PET amyloid-BETA IN THE DIAGNOSIS AND CONTROL CLINIC OF patients with cognitive impairment EVALUATED BY SUSPECTED Alzheimer's disease (AD).
Research Categorization
Primary Disease / Condition
Alzheimer's Disease
CADRO
Category B. Diagnosis, Assessment, and Disease Monitoring
2. Imaging Biomarkers
a. PET Amyloid Imaging
Researcher and Organization
Principal Investigator
ARBIZU LOSTAO, JAVIER
Principal Investigator First Name
JAVIER
Principal Investigator Last Name
ARBIZU LOSTAO
Awardee Organization
FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE NAVARRA
Contact PI Country
Spain
Project Detail
Funding Opportunity Announcement
PLAN ESTATAL DE INVESTIGACIÓN CIENTÍFICA Y TÉCNICA Y DE INNOVACIÓN 2013-2016
FY Overall Cost
$19,713
Funding Organization
Agency/Funding Organization
INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD
Funding Organization Country
Spain
Special Initiative
EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)

You might be interested in other related resources and tools...